MADISON, Wis. and PHOENIX, March 3, 2020 /PRNewswire/ -- (NASDAQ: EXAS) – Exact Sciences Corp. today announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two ...
MADISON, Wis. - Exact Sciences Corp. (NASDAQ: NASDAQ:EXAS), a prominent cancer screening and diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
Exact Sciences Corp. (NASDAQ: EXAS) is on a self-proclaimed mission to change the way cancer is detected and treated. The Madison, Wisconsin company is among the market’s best price performers, ...
(Reuters) - Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results